F&P Healthcare names First NZ Capital's St John to board
Scott St John will succeed Mr France as chairman of the company's audit & risk committee.
Fisher & Paykel Healthcare [NZX: FPH], which is aiming to lift annual revenue to $1 billion in the next three years, named First NZ Capital chief Scott St John as an independent, non-executive director starting on October 1.
The manufacturer of breathing devices and respirators said Mr St John, who has been chief executive of First NZ Capital since 2002, would help strengthen the board and ensure a smooth transition when Roger France retires this year after six years as a director.
St John will succeed Mr France as chairman of the company's audit & risk committee. A resolution to elect St John as a director will be put to shareholders at their annual meeting.
Last month, F&P Healthcare lifted its forecast for 2016 profit to a range of $135-140 million, on the proviso that the New Zealand dollar holds at about 65USc for the rest of the year. That's up about $10 million from its May guidance. Some 99% of the company's revenue is generated outside of New Zealand and the company benefits from a weaker kiwi, which was recently at 62.88USc.
(BusinessDesk)
Jonathan Underhill
Fri, 11 Sep 2015
Fri, 11 Sep 2015
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
F&P Healthcare names First NZ Capital's St John to board
51453